These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22374205)

  • 1. How's my dosing? A one-step, math-free guide for comparing your clinic's maintenance immunotherapy doses to current practice parameter recommendations.
    Grier TJ
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):201-5. PubMed ID: 22374205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Math-free guides for glycerin and allergens at variable subcutaneous injection volumes: How's my dosing? Update.
    Grier TJ; Converse LM; Rekkerth DJ; Renahan KE
    Ann Allergy Asthma Immunol; 2016 May; 116(5):455-60. PubMed ID: 27017565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of standardized extracts in allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):41-5. PubMed ID: 10887303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of allergen immunotherapy practice parameters on cat extract prescribing patterns, 1993-2009.
    Robertson BD; McCoy RL; Nelson MR; Haymore BR
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):437-40. PubMed ID: 22018616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration.
    Larenas-Linnemann DE; Gupta P; Mithani S; Ponda P
    Ann Allergy Asthma Immunol; 2012 May; 108(5):373-378.e3. PubMed ID: 22541411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
    Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units.
    Larenas-Linnemann D; Esch R; Plunkett G; Brown S; Maddox D; Barnes C; Constable D
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):448-458.e3. PubMed ID: 22018618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergen stabilities and compatibilities in mixtures of high-protease fungal and insect extracts.
    Grier TJ; LeFevre DM; Duncan EA; Esch RE; Coyne TC
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):439-47. PubMed ID: 22626598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunotherapy with allergen mixes: what is the evidence?
    Nelson HS
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):549-53. PubMed ID: 19745727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based dosing of maintenance subcutaneous immunotherapy: a contemporary review of state-of-the-art practice.
    Hoover H; Leatherman B; Ryan M; McMains K; Veling M
    Int Forum Allergy Rhinol; 2018 Jul; 8(7):806-816. PubMed ID: 29631326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of standardized grass, dust mite, cat, and short ragweed allergens after mixing with mold or cockroach extracts.
    Grier TJ; LeFevre DM; Duncan EA; Esch RE
    Ann Allergy Asthma Immunol; 2007 Aug; 99(2):151-60. PubMed ID: 17718103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European allergen extract units and potency: review of available information.
    Larenas-Linnemann D; Cox LS;
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):137-45. PubMed ID: 18320915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing of European sublingual immunotherapy maintenance solutions relative to monthly recommended dosing of subcutaneous immunotherapy.
    Larenas-Linnemann DE; Mösges R
    Allergy Asthma Proc; 2016; 37(1):50-6. PubMed ID: 26831847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phleum pratense alone is sufficient for allergen-specific immunotherapy against allergy to Pooideae grass pollens.
    Hejl C; Wurtzen PA; Kleine-Tebbe J; Johansen N; Broge L; Ipsen H
    Clin Exp Allergy; 2009 May; 39(5):752-9. PubMed ID: 19222498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability and mixing compatibility of dog epithelia and dog dander allergens.
    Grier TJ; LeFevre DM; Duncan EA; Esch RE
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):411-7. PubMed ID: 19927540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in upper airway diseases and allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imported fire ant immunotherapy prescribing patterns in a large health care system during a 17-year period.
    Haymore BR; McCoy RL; Nelson MR
    Ann Allergy Asthma Immunol; 2009 May; 102(5):422-5. PubMed ID: 19492665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
    Esch RE; Bush RK; Peden D; Lockey RF
    Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'.
    Calderón MA; Larenas D; Kleine-Tebbe J; Jacobsen L; Passalacqua G; Eng PA; Varga EM; Valovirta E; Moreno C; Malling HJ; Alvarez-Cuesta E; Durham S; Demoly P
    Allergy; 2011 Oct; 66(10):1345-59. PubMed ID: 21707645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.